politics
FDA Authorizes Glas Inc. Mango, Blueberry, and Menthol Vape Products
The Food and Drug Administration has authorized Los Angeles-based Glas Inc. to sell fruit-flavored vape pods for the first time under the Trump administration. The decision reverses the Biden administration's rejection of more than 26 million flavored vape applications. Anti-smoking groups expressed disappointment while the White House cited evidence-based policymaking.
May 7, 3:18 AM·2m read1 source
Substrate placeholder — needs reviewAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The Food and Drug Administration authorized Glas Inc. to sell mango and blueberry-flavored vape products. The agency also authorized the company's Classic Menthol and Fresh Menthol products as well as mango-flavored pods dubbed Gold and blueberry-flavored pods dubbed Sapphire.
Each authorized Glas Inc. product contains 5% tobacco-derived nicotine. Glas Inc. is based in Los Angeles. The decision marks the first authorization of fruit-flavored vape products by the FDA under President Trump.
Other authorized e-cigarette products from companies like Juul Labs are either menthol or tobacco-flavored. The Biden administration rejected more than 26 million applications for flavored vape products. In 2025 the Supreme Court ruled in a unanimous decision that the FDA could deny authorization for vape products that it believes may appeal to children.
Vape manufacturers argue the products can help adult smokers quit using cigarettes by offering a less harmful alternative. President Trump pressed FDA commissioner Dr. Marty Makary to allow the flavored vape products to be sold.
President Trump chastised Makary for not moving quicker on the flavored vape issue over the weekend. President Trump sought information from his advisors about how his base thought about the issue of vapes. White House spokesperson Kush Desai stated that the Biden administration cracked down on flavored vapes despite evidence that the products help adults quit smoking.
“The only factor guiding the Trump administration’s health policymaking is Gold Standard Science, and the FDA under Commissioner Makary’s trailblazing leadership will continue to make evidence-based decisions that rectify the Biden administration’s missteps and that are in the best interest of the American people,” Kush Desai stated.
